These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7931060)

  • 1. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.
    Cella M; Longo A; Ferrara GB; Strominger JL; Colonna M
    J Exp Med; 1994 Oct; 180(4):1235-42. PubMed ID: 7931060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.
    Mandelboim O; Reyburn HT; Valés-Gómez M; Pazmany L; Colonna M; Borsellino G; Strominger JL
    J Exp Med; 1996 Sep; 184(3):913-22. PubMed ID: 9064351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).
    Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A
    J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones.
    Luque I; Solana R; Galiani MD; González R; García F; López de Castro JA; Peña J
    Eur J Immunol; 1996 Aug; 26(8):1974-7. PubMed ID: 8765048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C.
    Colonna M; Brooks EG; Falco M; Ferrara GB; Strominger JL
    Science; 1993 May; 260(5111):1121-4. PubMed ID: 8493555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.
    Colonna M; Borsellino G; Falco M; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12000-4. PubMed ID: 8265660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
    Falk CS; Steinle A; Schendel DJ
    J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
    Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
    J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.
    Foley BA; De Santis D; Van Beelen E; Lathbury LJ; Christiansen FT; Witt CS
    Blood; 2008 Jul; 112(2):435-43. PubMed ID: 18385451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.
    Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
    J Exp Med; 1993 Oct; 178(4):1321-36. PubMed ID: 8376937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
    Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
    J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected Bw4 and Bw6 reactivity patterns in new alleles.
    Voorter CE; van der Vlies S; Kik M; van den Berg-Loonen EM
    Tissue Antigens; 2000 Oct; 56(4):363-70. PubMed ID: 11098937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.
    Biassoni R; Falco M; Cambiaggi A; Costa P; Verdiani S; Pende D; Conte R; Di Donato C; Parham P; Moretta L
    J Exp Med; 1995 Aug; 182(2):605-9. PubMed ID: 7629517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation.
    van der Ploeg K; Le Luduec JB; Stevenson PA; Park S; Gooley TA; Petersdorf EW; Shaffer BC; Hsu KC
    Blood Adv; 2020 Oct; 4(19):4955-4964. PubMed ID: 33049053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
    Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
    Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?
    Demanet C; Mulder A; Deneys V; Worsham MJ; Maes P; Claas FH; Ferrone S
    Blood; 2004 Apr; 103(8):3122-30. PubMed ID: 15070694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
    Sanjanwala B; Draghi M; Norman PJ; Guethlein LA; Parham P
    J Immunol; 2008 Nov; 181(9):6293-300. PubMed ID: 18941220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
    Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
    J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.